This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Apolipoprotein E (Apo-E)P02649Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and their Microparticles.
J Proteome Res. 2016 Oct 19.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Thymic exosomes promote the final maturation of thymocytes.
Sci Rep. 2016 Nov 8;6:36479. doi: 10.1038/srep36479.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Application of nano-LC-MALDI-TOF/TOF-MS for proteomic analysis of microvesicles.
Clin Biochem. 2016 Nov 16. pii: S0009-9120(16)30570-7. doi: 10.1016/j.clinbiochem.2016.11.013.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content.
Sci Rep. 2016 Dec 5;6:37871. doi: 10.1038/srep37871.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content.
Sci Rep. 2016 Dec 5;6:37871. doi: 10.1038/srep37871.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.
Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14964.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.
Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14964.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.
Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14964.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.
Sci Rep. 2017 Feb 20;7:42741. doi: 10.1038/srep42741.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.
Sci Rep. 2017 Feb 20;7:42741. doi: 10.1038/srep42741.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative changes in the protein and miRNA cargo of plasma exosome-like vesicles after exposure to ionizing radiation.
Int J Radiat Biol. 2017 Mar 7:1-12. doi: 10.1080/09553002.2017.1294772.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Quantitative changes in the protein and miRNA cargo of plasma exosome-like vesicles after exposure to ionizing radiation.
Int J Radiat Biol. 2017 Mar 7:1-12. doi: 10.1080/09553002.2017.1294772.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Residual urinary extracellular vesicles in ultracentrifugation supernatants after hydrostatic filtration dialysis enrichment.
J Extracell Vesicles. 2016 Dec 23;6(1):1267896. doi: 10.1080/20013078.2016.1267896. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein EF1RM45Revelation of mRNAs and proteins in porcine milk exosomes by transcriptomic and proteomic analysis.
BMC Vet Res. 2017 Apr 13;13(1):101. doi: 10.1186/s12917-017-1021-8.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.
Theranostics. 2017 Mar 16;7(5):1333-1345. doi: 10.7150/thno.17092. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth.
Theranostics. 2017 Mar 16;7(5):1333-1345. doi: 10.7150/thno.17092. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Differential protein expression in exosomal samples taken from trauma patients.
Proteomics Clin Appl. 2017 May 25. doi: 10.1002/prca.201700061.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.
Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17787.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2.
Nat Commun. 2017 Jun 6;8:15729. doi: 10.1038/ncomms15728.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2.
Nat Commun. 2017 Jun 6;8:15729. doi: 10.1038/ncomms15728.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P08226Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity.
Sci Rep. 2017 Jul 5;7(1):4711. doi: 10.1038/s41598-017-05002-y.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity.
Sci Rep. 2017 Jul 5;7(1):4711. doi: 10.1038/s41598-017-05002-y.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
Front Pharmacol. 2017 Jun 29;8:398. doi: 10.3389/fphar.2017.00398. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
Front Pharmacol. 2017 Jun 29;8:398. doi: 10.3389/fphar.2017.00398. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
Front Pharmacol. 2017 Jun 29;8:398. doi: 10.3389/fphar.2017.00398. eCollection 2017.
ENOG4111MYC347 / 0 / 347
Apolipoprotein E (Apo-E)P02649Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG4111MYC347 / 0 / 347
< [3] [4]